BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15737992)

  • 1. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
    Hu J; Hubbard SR
    J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
    Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
    J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
    Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
    PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS.
    Hu J; Hubbard SR
    J Mol Biol; 2006 Aug; 361(1):69-79. PubMed ID: 16824542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
    Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
    Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex.
    Wilcox A; Katsanakis KD; Bheda F; Pillay TS
    J Biol Chem; 2004 Sep; 279(37):38881-8. PubMed ID: 15231829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
    Ahmed Z; Pillay TS
    Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor.
    Hu J; Liu J; Ghirlando R; Saltiel AR; Hubbard SR
    Mol Cell; 2003 Dec; 12(6):1379-89. PubMed ID: 14690593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the TKB domain of ubiquitin ligase Cbl-b complexed with its small inhibitory peptide, Cblin.
    Ohno A; Ochi A; Maita N; Ueji T; Bando A; Nakao R; Hirasaka K; Abe T; Teshima-Kondo S; Nemoto H; Okumura Y; Higashibata A; Yano S; Tochio H; Nikawa T
    Arch Biochem Biophys; 2016 Mar; 594():1-7. PubMed ID: 26874193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
    de Melker AA; van der Horst G; Borst J
    J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling.
    Ahn MY; Katsanakis KD; Bheda F; Pillay TS
    J Biol Chem; 2004 May; 279(20):21526-32. PubMed ID: 15031295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding.
    Sun Q; Ng C; Guy GR; Sivaraman J
    FEBS Lett; 2011 Jan; 585(2):281-5. PubMed ID: 21163258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association.
    van Leeuwen JE; Paik PK; Samelson LE
    J Biol Chem; 1999 Feb; 274(8):5153-62. PubMed ID: 9988765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
    Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
    J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.
    Takeshita K; Tezuka T; Isozaki Y; Yamashita E; Suzuki M; Kim M; Yamanashi Y; Yamamoto T; Nakagawa A
    J Biochem; 2012 Nov; 152(5):487-95. PubMed ID: 22888118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.